Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report. (CROSBI ID 513796)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Tarle, Marko ; Kraljić, Ivo ; Kovačić, Ksenija
engleski
Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.
In a case of Stage D3 prosatte cancer we have shown the superiority of phase II protocol over phase I with a substantail improvement in PSA and PAP level and even more in none metastases.
prostate cancer; Stage D3; chemotherapy; advantage phase II over phase I protocol; improvement in bone lesions
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
363-363-x.
2002.
objavljeno
Podaci o matičnoj publikaciji
Book of Abstracts, The 12th International Prostate Cancer Update
David E Crawford
Denver (CO): ICPME
Podaci o skupu
The 12th International Prostate Cancer Update
predavanje
06.02.2002-10.02.2002
Keystone (CO), Sjedinjene Američke Države
